Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
164,213,918
-
Share change
-
+153,986
-
Total reported value
-
$727,463,387
-
Put/Call ratio
-
0.11%
-
Price per share
-
$4.43
-
Number of holders
-
222
-
Value change
-
+$1,737,232
-
Number of buys
-
106
-
Number of sells
-
112
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q4 2024
As of 31 Dec 2024,
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
164,213,918 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Sarissa Capital Management LP, Pacer Advisors, Inc., ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, BRAIDWELL LP, Kynam Capital Management, LP, and LSV ASSET MANAGEMENT.
This page lists
222
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.